SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alexandria Real Estate Equities

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Alexandria To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Alexandria between January 27, 2025 and October 27, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh […]

CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm

LOS ANGELES, Dec. 17, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of policyholders of Aetna Medicare Advantage plans through CVS Health Corporation (“CVS”) for breach of contract and related violations of state laws. The investigation focuses on whether CVS/Aetna wrongfully denied prior

CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm

CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm GlobeNewswire December 17, 2025 LOS ANGELES, Dec. 17, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of policyholders of Aetna

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Synopsys

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Synopsys To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Synopsys between December 4, 2024 and September 9, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh

Carnegie Hall Partners with Stardog to Introduce AI-Powered Tool Helping Visitors to Explore 130+ Years of Performance History

Carnegie Hall, one of the world's greatest concert halls, is partnering with leading AI and knowledge graph company Stardog to introduce an AI-powered tool that helps online visitors to search and explore the Hall's vast performance database of more than 62,000 events. https://mma.prnewswire.com/media/2847760/Stardog_Logo.jpg This new digital resource invites everyone-from music lovers and students to historians

Ecommerce Enters a Defining Year: 5 Predictions for 2026

ChannelEngine's 2026 predictions reveal that AI-driven discovery, marketplace diversification, and social commerce will transform how brands reach consumers An expert discussion among leaders from ChannelEngine, Salsify, and ZEOS by Zalando highlights 2026 as a defining year for global ecommerce. AI-driven discovery, marketplace diversification, and social commerce acceleration are reshaping how consumers search, compare, and purchase

MOBILion Systems Demonstrates a New Paradigm in Mass-Spectrometry-Based Proteomics

In 2025, MOBILion Systems achieved a decisive technical milestone through proof-of-concept demonstration that high-resolution ion mobility (HRIM), operated in MOBILion's unique PAMAF mode, fundamentally reshapes mass-spectrometry-based proteomics. This work empirically demonstrates what the field has theorized for more than two decades and does so in a way existing technologies are unable to match. https://mma.prnewswire.com/media/1831641/MOBILion_Logo.jpg More

Hidden Work and Shadow AI Are Driving Health System AI Pilots, New Findings Show

Black Book Market Research finds fewer than 1 in 5 health systems report mature AI governance and most undercount staff time spent supervising and correcting AI output NEW YORK CITY, NEW YORK / ACCESS Newswire / December 17, 2025 / A new national study from Black Book Market Research reveals that while AI pilots are

UPDATE — Acrivon Therapeutics to Announce Clinical Update on its Ongoing Phase 2b Studies and Planned Confirmatory Phase 3 Trial for ACR-368, Initial Clinical Data on ACR-2316, and Other AP3 Pipeline Updates via Webcast

(NasdaqGM:ACRV), WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing precision medicines utilizing its proprietary Generative Phosphoproteomics AP3 (Acrivon Predictive Precision Proteomics) platform designed to interpret and quantify global compound-specific, drug-regulated effects in the intact cell which is deployed

RLWRLD Wins Foundation Models Category at Nebius Robotics & Physical AI Awards

(NASDAQ:NBIS), MOUNTAIN VIEW, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) — RLWRLD, a Physical AI startup building robotics foundation models for real-world deployment, has won first place in the Foundation Models, Robot Brains and Runtime category at the 2025 Nebius Robotics & Physical AI Awards, a global competition recognizing early-stage companies advancing next-generation robotics and Physical

Scroll to Top